An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01876849 · COMPLETED
Trial details
- NCT number
- NCT01876849
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2008-07-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.